NOV 11, 2020 12:30 PM PST

Who Gets Cannabis Use Disorder? A Risk Prediction model Could Find Out

WRITTEN BY: Angela Dowden

Along with the benefits of cannabis come some downsides. One of these is cannabis use disorder (CUD), which is predicted to increase as legalization of cannabis spreads.

Recognized as a defined mental health ailment by the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, cannabis use disorder is defined as taking cannabis in larger amounts, or over a longer period, than intended. Usually people want to cut down but find it almost impossible to do so. Consequently, those with CUD will spend a great deal of time in activities necessary to obtain cannabis, use the drug or recover from its effects.

A number of potential risk factors for the disorder have been put forward, and a genetic link established but in a new twist, mathematicians at the University of Texas, Dallas have built mathematical prediction models to predict the risk of cannabis use disorder for a user.

After experimenting with several statistical and machine learning models for classification, penalized logistic regression with LASSO was the data analysis method the researchers used. They chose LASSO because it allowed the ability to interpret the effects of risk factors quantitatively, a feature unavailable in the other methods.

The analysis was very much a pilot study as it looked at only 118 cannabis users. However, in the end, the final LASSO model predicted the CUD status with 66% accuracy — an impressive result. Higher risk of CUD was associated with younger age, lower level of enjoyment from initial smoking, higher score on impulsivity, greater cognitive instability, higher neuroticism (i.e. more prone to experience negative feelings), greater openness to new experiences, and lower conscientiousness.

Though complete data on more subjects would have provided higher power for identifying association, the researchers have proven a concept that prediction models could prove useful in pinpointing who might be vulnerable to cannabis use disorder in future.

As the researchers note: “Our findings may provide insights into future trends related to continued changes in cannabis legislation in the US”.

Sources: Science Direct, Psycom

 

About the Author
  • I'm a journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
AUG 26, 2021
Microbiology
Some Herbal Medicines May Help Treat Tick-Borne Diseases
AUG 26, 2021
Some Herbal Medicines May Help Treat Tick-Borne Diseases
Ticks are vectors for disease; they can transmit pathogenic bacteria to animals and humans through their bites. Diseases ...
AUG 27, 2021
Earth & The Environment
Reducing our Waste Problem
AUG 27, 2021
Reducing our Waste Problem
The generation of waste in most of our lives is astounding. We throw much of what we use in the garbage. On average, Ame ...
AUG 29, 2021
Cancer
Blood Test over 90% Accurate in Detecting Lung Cancer
AUG 29, 2021
Blood Test over 90% Accurate in Detecting Lung Cancer
An AI-powered blood test was able to correctly detect the presence of lung cancer over 90% of the time in patient sample ...
SEP 02, 2021
Immunology
Will an Extra COVID Vaccine Shot Benefit People With Autoimmune Conditions?
SEP 02, 2021
Will an Extra COVID Vaccine Shot Benefit People With Autoimmune Conditions?
The global rollout of COVID-19 vaccines has helped save countless lives during the pandemic. Studies have shown that vac ...
SEP 05, 2021
Cardiology
Eating Walnuts & Pecans Can Help Lower 'Bad' Cholesterol
SEP 05, 2021
Eating Walnuts & Pecans Can Help Lower 'Bad' Cholesterol
Some nuts, especially walnuts, have high levels of healthy fats like Omega-3. New research reported in Circulation has s ...
SEP 16, 2021
Drug Discovery & Development
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
SEP 16, 2021
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
According to the Population Reference Bureau, 40 million people in the United States are aged 65 and older. This nu ...
Loading Comments...